National Cancer Institute
Found 939 results for your search:
Total relevant funding to Leukemia for this search:
$241,005,895
Fiscal Year FY 2016
Cancer Type [Leukemia]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 939 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy 1R21CA205644-01 $167,475 $167,475 WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
2
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression 1R01CA205975-01A1 $386,619 $386,619 GHAFFARI, SAGHI ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
3
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia 5R01CA185062-03 $312,341 $312,341 FARRAR, MICHAEL UNIVERSITY OF MINNESOTA
4
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data 5R01CA185486-03 $517,690 $258,845 RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES
5
(PQC2) Localization as a determinant of cancer dormancy 5R01CA194596-02 $527,391 $527,391 LIN, CHARLES MASSACHUSETTS GENERAL HOSPITAL
6
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL 5R01CA184922-03 $553,684 $553,684 WU, CATHERINE DANA-FARBER CANCER INST
7
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers 4R01CA180037-04 $328,888 $328,888 SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
8
5-hydroxymethylcytosine in human cancer 5R01CA160965-05 $394,250 $197,125 PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE
9
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $44,764 $17,906 Rothman, Nathaniel DCEG (NCI)
10
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOM ZIA CP010121-10363 $85,112 $85,112 Lan, Qing DCEG (NCI)
11
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia 5R01CA190843-02 $311,458 $155,729 SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY
12
A Mouse Model of DNMT3A-Associated Hematologic Malignancy 5R01CA183252-03 $537,748 $537,748 GOODELL, MARGARET BAYLOR COLLEGE OF MEDICINE
13
A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia 1R43CA203172-01 $278,000 $278,000 MU, XUEYAN TEAMEDON INTERNATIONAL, LLC
14
A novel hematopoietic stem cell population 4F31CA180604-03 $48,576 $48,576 BALCEREK, JOANNA UNIVERSITY OF PENNSYLVANIA
15
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia 5R03CA191983-02 $79,500 $79,500 LAVAU, CATHERINE DUKE UNIVERSITY
16
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment 4R00CA183914-03 $248,999 $248,999 WAN, LIXIN H. LEE MOFFITT CANCER CTR & RES INST
17
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease 1R01CA201719-01 $361,499 $180,750 GAMBHIR, SANJIV STANFORD UNIVERSITY
18
A Pathway of Tumor Suppression 4R01CA047296-28 $249,580 $82,361 LOZANO, GUILLERMINA UNIVERSITY OF TX MD ANDERSON CAN CTR
19
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD 5R44CA192601-02 $467,137 $233,569 FLAIM, JOANN TARGAZYME, INC.
20
A rapid spontaneous murine model of CN-AML 1R01CA196658-01A1 $625,379 $625,379 GRIMES, H. CINCINNATI CHILDRENS HOSP MED CTR
21
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $268,745 $26,875 Tosato, Giovanna CCR (NCI)
22
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,229,987 $61,499 Sinha, Rashmi DCEG (NCI)
23
Aberrant signaling in acute myeloid leukemia 1R01CA204396-01A1 $459,674 $459,674 KENTSIS, ALEX SLOAN-KETTERING INST CAN RESEARCH
24
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $398,777 DANG, CHI UNIVERSITY OF PENNSYLVANIA
25
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $1,563 DANG, CHI UNIVERSITY OF PENNSYLVANIA
26
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $24,998 DANG, CHI UNIVERSITY OF PENNSYLVANIA
27
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $10,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
28
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $322,076 $161,038 Aplan, Peter CCR (NCI)
29
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment 1R01CA201444-01A1 $413,948 $413,948 MITTELMAN, STEVEN CHILDREN'S HOSPITAL OF LOS ANGELES
30
Adoptive T cell Therapy for Pediatric Leukemia ZIA BC 011565 $1,035,891 $1,035,891 Fry, Terry CCR (NCI)
31
Adult Leukemia Research Center 4P01CA018029-41 $4,225,448 $3,422,613 APPELBAUM, FREDERICK FRED HUTCHINSON CANCER RESEARCH CENTER
32
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations 5R33CA192980-02 $375,858 $375,858 SALIPANTE, STEPHEN UNIVERSITY OF WASHINGTON
33
Aging-associated alterations in adaptive landscapes and the evolution of leukemia 4R01CA180175-04 $344,974 $344,974 DEGREGORI, JAMES UNIVERSITY OF COLORADO DENVER
34
ALL immunobiology and the bone marrow niche ZIA BC 011295 $443,953 $443,953 Fry, Terry CCR (NCI)
35
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S1 $1,595,651 $239,348 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
36
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S2 $550,000 $82,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
37
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S3 $750,000 $112,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
38
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-03 $9,068,022 $1,360,203 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
39
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $41,944 $28,103 Kochenderfer, James CCR (NCI)
40
Analysis of TET2 function in acute leukemia 1K08CA181507-01A1 $180,036 $180,036 SHIH, ALAN SLOAN-KETTERING INST CAN RESEARCH
41
Anatomic Pathology Residency Program ZIE BC 011384 $1,014,935 $40,597 Barr, Frederic CCR (NCI)
42
ARID5B and disparities of childhood leukemia 3U01CA176063-03S1 $99,152 $99,152 YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
43
ARID5B and disparities of childhood leukemia 3U01CA176063-03S2 $199,999 $199,999 YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
44
ARID5B and disparities of childhood leukemia 5U01CA176063-03 $365,074 $365,074 YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
45
Arsenic Trioxide activated pathways in malignant cells 4R01CA121192-10 $266,285 $266,285 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
46
Assay Development for NSD1 Methyltransferase Inhibitor Discovery 5R01CA191077-02 $312,244 $312,244 NAPPER, ANDREW ALFRED I. DU PONT HOSP FOR CHILDREN
47
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS 4R01CA163653-04 $323,864 $323,864 KOPAN, RAPHAEL CINCINNATI CHILDRENS HOSP MED CTR
48
ATBC Study ZIA CP010195-03031 $1,193,520 $35,806 Albanes, Demetrius DCEG (NCI)
49
Baylor College of Medicine Cancer Center 3P30CA125123-10S1 $118,016 $11,802 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
50
Baylor College of Medicine Cancer Center 3P30CA125123-10S2 $170,897 $17,090 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
Total relevant funding to Leukemia for this search: $241,005,895
Showing 1 - 50 of 939 results
Go to top